CO6150168A2 - Combinaciones farmacologicas que comprenden benzoxazinonas para el tratamiento de enfermedades de las vias aereas - Google Patents
Combinaciones farmacologicas que comprenden benzoxazinonas para el tratamiento de enfermedades de las vias aereasInfo
- Publication number
- CO6150168A2 CO6150168A2 CO09016427A CO09016427A CO6150168A2 CO 6150168 A2 CO6150168 A2 CO 6150168A2 CO 09016427 A CO09016427 A CO 09016427A CO 09016427 A CO09016427 A CO 09016427A CO 6150168 A2 CO6150168 A2 CO 6150168A2
- Authority
- CO
- Colombia
- Prior art keywords
- compounds
- pharmacological combinations
- pharmacological
- benzoxazinonas
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pregnancy & Childbirth (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
1.- Combinaciones farmacológicas que, además de uno o varios compuestos de la fórmula general 1en donde R1 y R2 son, de modo independiente entre sí, H, halógeno o alquilo C1-4 o juntos son alquileno C1-6; y R3 es H, halógeno, OH, alquilo C1-4 u O-alquilo C1-4, contienen al menos otro principio activo 2. 2.- Combinaciones farmacológicas de acuerdo con la reivindicación 1 que, además de uno o varios compuestos de la fórmula 1 contienen como otro principio activo 2 uno o varios compuestos que están seleccionados de las clases de los anticolinérgicos (2a), inhibidores de PDE IV (2b), esteroides (2c), antagonistas de LTD4 (2d) e inhibidores de EGFR (2e). 3.- Combinaciones farmacológicas de acuerdo con la reivindicación 1 ó 2, que contienen uno o varios compuestos de la fórmula general 1, en donde R1 y R2 iguales o diferentes, hidrógeno, flúor, cloro, metilo, etilo, propilo, butilo o conjuntamente -CH2-CH2-, -CH2-CH2-CH2-, -CH2-CH2-CH2-CH2- o -CH2-CH2-CH2-CH2-CH2-; hidrógeno, flúor, cloro, OH, metilo, etilo, metoxi o etoxi. 4.- Combinaciones farmacológicas de acuerdo con la reivindicación 1, 2 ó 3, que contienen uno o varios compuestos de la fórmula general 1, en donde R1 y R2 iguales o diferentes, etilo, propilo o conjuntamente -CH2-CH2-, -CH2-CH2-CH2-, -CH2-CH2-CH2-CH2- o -CH2-CH2-CH2-CH2-CH2-; R3 hidrógeno, flúor, OH, metilo o metoxi.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06119272 | 2006-08-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6150168A2 true CO6150168A2 (es) | 2010-04-20 |
Family
ID=38535607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO09016427A CO6150168A2 (es) | 2006-08-22 | 2009-02-19 | Combinaciones farmacologicas que comprenden benzoxazinonas para el tratamiento de enfermedades de las vias aereas |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20080051392A1 (es) |
| EP (1) | EP2094271A2 (es) |
| JP (1) | JP2010501521A (es) |
| KR (1) | KR20090047539A (es) |
| CN (1) | CN101505757A (es) |
| AR (1) | AR062475A1 (es) |
| AU (1) | AU2007287536A1 (es) |
| BR (1) | BRPI0715855A2 (es) |
| CA (1) | CA2661496A1 (es) |
| CO (1) | CO6150168A2 (es) |
| EA (1) | EA200900269A1 (es) |
| EC (1) | ECSP099080A (es) |
| IL (1) | IL197125A0 (es) |
| MX (1) | MX2009001355A (es) |
| NO (1) | NO20090067L (es) |
| PE (1) | PE20081358A1 (es) |
| TW (1) | TW200817009A (es) |
| UY (1) | UY30552A1 (es) |
| WO (1) | WO2008023003A1 (es) |
| ZA (1) | ZA200810828B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005008921A1 (de) * | 2005-02-24 | 2006-08-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
| US7423146B2 (en) * | 2005-11-09 | 2008-09-09 | Boehringer Ingelheim International Gmbh | Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones |
| PE20080610A1 (es) * | 2006-08-22 | 2008-07-15 | Boehringer Ingelheim Int | Nuevos beta-agonistas enantiomericamente puros, procedimientos para su preparacion y uso como medicamentos |
| EP2093219A1 (de) | 2008-02-22 | 2009-08-26 | Boehringer Ingelheim International Gmbh | Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel |
| WO2011061527A1 (en) | 2009-11-17 | 2011-05-26 | Astrazeneca Ab | Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases |
| GB201016912D0 (en) | 2010-10-07 | 2010-11-24 | Astrazeneca Ab | Novel combination |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3026534A1 (de) * | 1980-07-12 | 1982-03-18 | C.H. Boehringer Sohn, 6507 Ingelheim | 3,1-benzoxazin-2-one, ihre herstellung und verwendung |
| US4570630A (en) * | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
| US4811731A (en) * | 1985-07-30 | 1989-03-14 | Glaxo Group Limited | Devices for administering medicaments to patients |
| WO2005013993A1 (en) * | 2003-07-29 | 2005-02-17 | Boehringer Ingelheim International Gmbh | Medicaments comprising pde iv inhibitors and an anticholinergic for treating respiratory disorders |
| DE102004048390A1 (de) * | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff |
| DE102005008921A1 (de) * | 2005-02-24 | 2006-08-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
| US7423146B2 (en) * | 2005-11-09 | 2008-09-09 | Boehringer Ingelheim International Gmbh | Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones |
-
2007
- 2007-08-20 UY UY30552A patent/UY30552A1/es not_active Application Discontinuation
- 2007-08-20 PE PE2007001123A patent/PE20081358A1/es not_active Application Discontinuation
- 2007-08-21 TW TW096130915A patent/TW200817009A/zh unknown
- 2007-08-21 WO PCT/EP2007/058653 patent/WO2008023003A1/de active Application Filing
- 2007-08-21 BR BRPI0715855-6A patent/BRPI0715855A2/pt not_active IP Right Cessation
- 2007-08-21 KR KR1020097005857A patent/KR20090047539A/ko not_active Application Discontinuation
- 2007-08-21 US US11/842,480 patent/US20080051392A1/en not_active Abandoned
- 2007-08-21 AU AU2007287536A patent/AU2007287536A1/en not_active Abandoned
- 2007-08-21 CN CNA2007800311850A patent/CN101505757A/zh active Pending
- 2007-08-21 EP EP07802745A patent/EP2094271A2/de not_active Withdrawn
- 2007-08-21 EA EA200900269A patent/EA200900269A1/ru unknown
- 2007-08-21 MX MX2009001355A patent/MX2009001355A/es not_active Application Discontinuation
- 2007-08-21 CA CA002661496A patent/CA2661496A1/en not_active Abandoned
- 2007-08-21 JP JP2009525051A patent/JP2010501521A/ja active Pending
- 2007-08-22 AR ARP070103720A patent/AR062475A1/es unknown
-
2008
- 2008-12-23 ZA ZA200810828A patent/ZA200810828B/xx unknown
-
2009
- 2009-01-06 NO NO20090067A patent/NO20090067L/no not_active Application Discontinuation
- 2009-01-19 EC EC2009009080A patent/ECSP099080A/es unknown
- 2009-02-19 IL IL197125A patent/IL197125A0/en unknown
- 2009-02-19 CO CO09016427A patent/CO6150168A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR062475A1 (es) | 2008-11-12 |
| IL197125A0 (en) | 2009-11-18 |
| CA2661496A1 (en) | 2008-02-28 |
| MX2009001355A (es) | 2009-02-13 |
| ECSP099080A (es) | 2009-02-27 |
| TW200817009A (en) | 2008-04-16 |
| EP2094271A2 (de) | 2009-09-02 |
| JP2010501521A (ja) | 2010-01-21 |
| PE20081358A1 (es) | 2008-10-31 |
| BRPI0715855A2 (pt) | 2013-07-30 |
| KR20090047539A (ko) | 2009-05-12 |
| WO2008023003A8 (de) | 2008-05-22 |
| AU2007287536A1 (en) | 2008-02-28 |
| CN101505757A (zh) | 2009-08-12 |
| UY30552A1 (es) | 2008-03-31 |
| US20080051392A1 (en) | 2008-02-28 |
| EA200900269A1 (ru) | 2009-08-28 |
| ZA200810828B (en) | 2009-11-25 |
| WO2008023003A1 (de) | 2008-02-28 |
| NO20090067L (no) | 2009-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR049262A1 (es) | Combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias | |
| PE20081362A1 (es) | DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K | |
| CO6150168A2 (es) | Combinaciones farmacologicas que comprenden benzoxazinonas para el tratamiento de enfermedades de las vias aereas | |
| CR8744A (es) | Compuestos terapeuticos | |
| CO6190521A2 (es) | Derivados de azacicloalcanos como inhibidores de estearoil-coenzima a delta -9 desaturasa | |
| AR072016A1 (es) | Derivados de isoxazol que funcionan como potenciadores de los receptores de glutamato | |
| AR059957A1 (es) | DERIVADOS DE ESPIROINDOLINONA, MÉTODOS PARA SU PREPARACIoN, UNA COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE Y SU USO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DEL CÁNCER. | |
| PE20070517A1 (es) | Derivados de imidazol como agentes inhibidores de la sintasa de aldosterona y aromatasa | |
| NO20092723L (no) | Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer | |
| CR7548A (es) | Derivados de triazole como antagonistas del receptor de tachykinin | |
| NO20073729L (no) | Heterocykliske forbindelser som CCR2B-antagonister | |
| IS8503A (is) | Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar | |
| ECSP045367A (es) | "derivados de bencimidazol utiles como antagonistas de histamina h3" | |
| ES2195785B1 (es) | Nuevos derivados de piridazin-3(2h)-ona. | |
| UY29002A1 (es) | Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia | |
| PE20050081A1 (es) | Nuevas imidazopirazinas como inhibidores de cinasas dependientes de ciclinas | |
| PE20090895A1 (es) | Derivados de triazol como inhibidores de la jak quinasa | |
| UY28572A1 (es) | Compuestos novedosos | |
| PE20071136A1 (es) | Derivados de anilina sustituida como antagonistas de la histamina h3 | |
| PE20060957A1 (es) | Compuestos pirazolopiridinas su preparacion y composiciones farmaceuticas | |
| UY29003A1 (es) | Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia | |
| CU20090048A7 (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| ATE502936T1 (de) | 2, 6-di-(hetero-)aryl-4-amido-pyrimidine als adenosin-rezeptor-antagonisten | |
| TW200800962A (en) | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | |
| AR059320A1 (es) | Composicion antitumorial que comprende un inhibidor de quinasas dependientes de ciclinas y un anticuerpo que inhibe un factor de crecimiento y/o un compuesto antimitotico |